IL-10 Cytokine Released from M2 Macrophages Is Crucial for Analgesic and Anti-inflammatory Effects of Acupuncture in a Model of Inflammatory Muscle Pain

Molecular Neurobiology

Volumn 51, Issue 1, 2015, Pages 19-31

  da Silva, Morgana D ^a,b   Bobinski, Franciane ^a   Sato, Karina L ^c   Kolker, Sandra J ^c   Sluka, Kathleen A ^c   Santos, Adair R S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Acupuncture; Edema; Hyperalgesia; IL 10 cytokine; Inflammation; Macrophage; Muscle; Nociception; Pain; SP6

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; CARRAGEENAN; INTERLEUKIN 10;

ACUPUNCTURE; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; COMPLICATION; DEFICIENCY; DISEASE MODEL; EDEMA; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KNOCKOUT MOUSE; MACROPHAGE; MALE; MUSCLE; MYALGIA; NOCICEPTION; PATHOLOGY; PHENOTYPE; SECRETION (PROCESS);

ACUPUNCTURE POINTS; ACUPUNCTURE THERAPY; ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; BEHAVIOR, ANIMAL; CARRAGEENAN; DISEASE MODELS, ANIMAL; EDEMA; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-10; MACROPHAGES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLES; MYALGIA; NOCICEPTION; PHENOTYPE;

EID: 84930182199     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-014-8790-x     Document Type: Article

References (59)

1. Ferrari R, Russell AS (2003) Regional musculoskeletal conditions: neck pain. Best Pract Res Clin Rheumatol 17:57–70. doi:10.1016/S1521-6942(02)00097-9
2. De Santana JM, Sluka KA (2008) Central mechanisms in the maintenance of chronic widespread noninflammatory muscle pain. Curr Pain Headache Rep 12(5):338–343. doi:10.1007/s11916-008-0057-7
3. Loram LC, Fuller A, Fick LG, Cartmell T, Poole S, Mitchell D (2007) Cytokine profiles during carrageenan-induced inflammatory hyperalgesia in rat muscle and hind paw. J Pain 8:127–136. doi:10.1016/j.jpain.2006.06.010
4. Radhakrishnan R, Moore SA, Sluka KA (2003) Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats. Pain 104:567–577. doi:10.1016/S0304-3959(03)00114-3
5. Philippou A, Maridaki M, Theos A, Koutsilieris M (2012) Cytokines in muscle damage. Adv Clin Chem 58:49–87
6. Lawrence T, Natoli G (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11:750–761. doi:10.1038/nri3088
7. Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11:723–737. doi:10.1038/nri3073
8. Sutterwala FS, Noel GJ, Clynes R, Mosser DM (1997) Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med 185:1977–1985. doi:10.1084/jem.185.11.1977
9. Sutterwala FS, Noel GJ, Salgame P, Mosser DM (1998) Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J Exp Med 188:217–222. doi:10.1084/jem.188.1.217
10. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, Chazaud B (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into anti-inflammatory macrophages to support myogenesis. J Exp Med 204:1057–1069. doi:10.1084/jem.20070075
11. Cheng RS, Pomeranz B (1981) Monoaminergic mechanism of electroacupuncture analgesia. Brain Res 215:77–92. doi:10.1016/0006-8993(81)90492-3
12. Cho ZH, Hwang SC, Wong EK, Son YD, Kang CK, Park TS, Bai SJ, Kim YB, Lee YB, Sung KK, Lee BH, Shepp LA, Min KT (2006) Neural substrates, experimental evidences and functional hypothesis of acupuncture mechanisms. Acta Neurol Scand 113:370–377. doi:10.1111/j.1600-0404.2006.00600.x
13. Goldman N, Chen M, Fujita T, Xu Q, Peng W, Liu W, Jensen TK, Pei Y, Wang F, Han X, Chen JF, Schnermann J, Takano T, Bekar L, Tieu K, Nedergaard M (2010) Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat Neurosci 13:883–888. doi:10.1038/nn.2562
14. Zhao ZQ (2008) Neural mechanism underlying acupuncture analgesia. Prog Neurobiol 85:355–375. doi:10.1016/j.pneurobio.2008.05.004
15. Zhang ZJ, Wang XM, Mcalonan GM (2012) Neural acupuncture unit: a new concept for interpreting effects and mechanisms of acupuncture. Evid Based Complement Alternat Med 2012:429412. doi:10.1155/2012/429412
16. da Silva MD, Guginski G, Werner MF, Baggio CH, Marcon R, Santos AR (2011) Involvement of interleukin-10 in the anti-inflammatory effect of Sanyinjiao (SP6) acupuncture in a mouse model of peritonitis. Evid Based Complement Alternat Med 2011:217946. doi:10.1093/ecam/neq036
17. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109–110. doi:10.1016/0304-3959(83)90201-4
18. Walder RY, Rasmussen LA, Rainier JD, Light AR, Wemmie JA, Sluka KA (2010) ASIC1 and ASIC3 play different roles in the development of hyperalgesia after inflammatory muscle injury. J Pain 11:210–218. doi:10.1016/j.jpain.2009.07.004
19. Yin CS, Jeong HS, Park HJ, Baik Y, Yoon MH, Choi CB, Koh HG (2008) A proposed transpositional acupoint system in a mouse and rat model. Res Vet Sci 84:159–165. doi:10.1016/j.rvsc.2007.04.004
20. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55–63. doi:10.1016/0165-0270(94)90144-9
21. Dixon WJ (1980) Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20:441–462. doi:10.1146/annurev.pa.20.040180.002301
22. Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77–88. doi:10.1016/0304-3959(88)90026-7
23. Kehl LJ, Trempe TM, Hargreaves KM (2000) A new animal model for assessing mechanisms and management of muscle hyperalgesia. Pain 85:333–343. doi:10.1016/S0304-3959(99)00282-1
24. Pratt D, Fuchs PN, Sluka KA (2013) Assessment of avoidance behaviors in mouse models of muscle pain. Neuroscience 248C:54–60. doi:10.1016/j.neuroscience.2013.05.058
25. Davies LC, Jenkins SJ, Allen JE, Taylor PR (2013) Tissue-resident macrophages. Nat Immunol 14(10):986–995. doi:10.1038/ni.2705
26. Laughlin TM, Bethea JR, Yezierski RP, Wilcox GL (2000) Cytokine involvement in dynorphin-induced allodynia. Pain 84(2–3):159–167. doi:10.1016/S0304-3959(99)00195-5
27. Kanaan SA, Poole S, Saadé NE, Jabbur S, Safieh-Garabedian B (1998) Interleukin-10 reduces the endotoxin-induced hyperalgesia in mice. J Neuroimmunol 86(2):142–150. doi:10.1016/S0165-5728(98)00027-7
28. Lau D, Harte SE, Morrow TJ, Wang S, Mata M, Fink DJ (2012) Herpes simplex virus vector-mediated expression of interleukin-10 reduces below-level central neuropathic pain after spinal cord injury. Neurorehabil Neural Repair 26(7):889–897. doi:10.1177/1545968312445637
29. Plunkett JA, Yu CG, Easton JM, Bethea JR, Yezierski RP (2001) Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp Neurol 168(1):144–154. doi:10.1006/exnr.2000.7604
30. Tu H, Juelich T, Smith EM, Tyring SK, Rady PL, Hughes TK Jr (2003) Evidence for endogenous interleukin-10 during nociception. J Neuroimmunol 139(1–2):145–149. doi:10.1016/s0165-5728(03)00126-7
31. Abraham KE, McMillen D, Brewer KL (2004) The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse. Neuroscience 124(4):945–952. doi:10.1016/j.neuroscience.2004.01.004
32. Shen KF, Zhu HQ, Wei XH, Wang J, Li YY, Pang RP, Liu XG (2013) Interleukin-10 down-regulates voltage gated sodium channels in rat dorsal root ganglion neurons. Exp Neurol 247:466–475. doi:10.1016/j.expneurol.2013.01.018
33. Vale ML, Marques JB, Moreira CA, Rocha FA, Ferreira SH, Poole S, Cunha FQ, Ribeiro RA (2003) Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats. J Pharmacol Exp Ther 304:102–108. doi:10.1124/jpet.102.038703
34. Laughlin TM, Bethea JR, Yezierski RP, Wilcox GL (2000) Cytokine involvement in dynorphin-induced allodynia. Pain 84:159–167. doi:10.1016/S0304-3959(99)00195-5
35. Okamoto K, Martin DP, Schmelzer JD, Mitsui Y, Low PA (2001) Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol 169:386–391. doi:10.1006/exnr.2001.7677
36. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958–969. doi:10.1038/nri2448
37. Meisel C, Vogt K, Platzer C, Randow F, Liebenthal C, Volk HD (1996) Differential regulation of monocytic tumor necrosis factor-alpha and interleukin-10 expression. Eur J Immunol 26:1580–1586. doi:10.1002/eji.1830260726
38. Platzer C, Volk HD, Platzer M (1994) 5′ Noncoding sequence of human IL-10 gene obtained by oligo-cassette PCR walking. DNA Seq 4:399–401. doi:10.3109/10425179409010188
39. Platzer C, Meisel C, Vogt K, Platzer M, Volk HD (1995) Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int Immunol 7:517–523. doi:10.1093/intimm/7.4.517
40. Platzer C, Fritsch E, Elsner T, Lehmann MH, Volk HD, Prösch S (1999) Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells. Eur J Immunol 29:3098–3104. doi:10.1002/(SICI)1521
41. Platzer C, Döcke W, Volk H, Prösch S (2000) Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. J Neuroimmunol 105:31–38. doi:10.1016/S0165-5728(00)00205-8
42. Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schöning B, Glöckner F, Lanksch WR, Volk HD, Döcke WD (1998) Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 4:808–813. doi:10.1038/nm0798-808
43. Yakeu G, Butcher L, Isa S, Webb R, Roberts AW, Thomas AW, Backx K, James PE, Morris K (2010) Low-intensity exercise enhances expression of markers of alternative activation in circulating leukocytes: roles of PPARγ and Th2 cytokines. Atherosclerosis 212:668–673. doi:10.1016/j.atherosclerosis.2010.07.002
44. Moore KW, de Waal MR, Coffman RL, O’Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683–765. doi:10.1146/annurev.immunol.19.1.683
45. Sabat R (2010) IL-10 family of cytokines. Cytokine Growth Factor Rev 21:315–324. doi:10.1016/j.cytogfr.2010.11.001
46. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG (2003) TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19:59–70. doi:10.1016/S1074-7613(03)00171-7
47. Lumeng CN, Deyoung SM, Saltiel AR (2007) Macrophages block insulin action in adipocytes by altering expression of signaling and glucose transport proteins. Am J Physiol Endocrinol Metab 292:E166–E174. doi:10.1152/ajpendo.00284.2006
48. Porcheray F, Viaud S, Rimaniol AC, Léone C, Samah B, Dereuddre-Bosquet N, Dormont D, Gras G (2005) Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 142:481–489. doi:10.1111/j.1365-2249.2005.02934.x
49. Martinez FO, Gordon S, Locati M, Mantovani A (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177:7303–7311
50. Ulett GA, Han S, Han JS (1998) Electroacupuncture: mechanisms and clinical application. Biol Psychiatry 44:129–138
51. Luo F, Wang JY (2008) Modulation of central nociceptive coding by acupoint stimulation. Neurochem Res 33:1950–1955. doi:10.1007/s11064-008-9692-y
52. Kim SK, Bae H (2010) Acupuncture and immune modulation. Auton Neurosci 157(1-2):38–41. doi:10.1016/j.autneu.2010.03.010
53. Hisamitsu T, Kasahara T, Umezawa T, Ishino T, Hisamitsu T (2002) The effect of acupuncture on natural killer cell activity. Int Congr Ser 1238:125–131. doi:10.3736/jintegrmed2013012
54. Yu Y, Kasahara T, Sato T, Asano K, Yu G, Fang J, Guo S, Sahara M, Hisamitsu T (1998) Role of endogenous interferon-gamma on the enhancement of splenic NK cell activity by electroacupuncture stimulation in mice. J Neuroimmunol 90:176–186
55. Chiu JH, Cheng HC, Tai CH, Hseih JC, Yeh TC, Cheng H, Lin JG, Ho LT (2001) Electroacupuncture-induced neural activation detected by use of manganese enhanced functional magnetic resonance imaging in rabbits. Am J Vet Res 62:178–182. doi:10.2460/ajvr.2001.62.178
56. Choi GS, Oh SD, Han JB, Bae HS, Cho YW, Yun YS, Lee WK, Ahn HJ, Min BI (2002) Modulation of natural killer cell activity affected by electroacupuncture through lateral hypothalamic area in rats. Neurosci Lett 329:1–4. doi:10.1016/S0304-3940(02)00551-7
57. Patterson SL, Sluka KA, Arnold MA (2001) A novel transverse push-pull microprobe: in vitro characterization and in vivo demonstration of the enzymatic production of adenosine in the spinal cord dorsal horn. J Neurochem 76(1):234–246. doi:10.1046/j.1471-4159.2001.00016.x
58. Goldman JW, Laux I, Chai F, Savage RE, Ferrari D, Garmey EG, Just RG, Rosen LS (2012) Phase 1 dose-escalation trial evaluating the combination of the selective MET (mesenchymal-epithelial transition factor) inhibitor tivantinib (ARQ 197) plus erlotinib. Cancer 118(23):5903–5911. doi:10.1002/cncr.27575
59. Dubyak GR (2012) P2X7 receptor regulation of non-classical secretion from immune effector cells. Cell Microbiol 14(11):1697–1706. doi:10.1111/cmi.12001